Atherothrombosis is a frequent complication of the clinical history of patients with antiphospholipid syndrome (APS). Both atherothrombosis and APS are characterized by increased oxidative stress. Oxidative modifications are implicated in the formation of antiphospholipid antibodies, which in turn may favour the oxidative imbalance by increasing the production of reactive oxidant species (ROS) or by a direct interaction with pro-oxidant/antioxidant enzymes. As a result of these processes, APS patients suffer from an oxidative imbalance that may contribute to the progression of the atherosclerotic process and to the onset of ischemic thrombotic complications. The aim of this review is to describe mechanisms implicated in the formation of ROS in APS patients and their involvement in the atherothrombotic process. We also provide an overview of potential therapeutic approaches to blunt oxidative stress and to prevent atherothrombotic complications in these patients.

Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process / Nocella, C.; Bartimoccia, S.; Cammisotto, V.; D'Amico, A.; Pastori, D.; Frati, G.; Sciarretta, S.; Rosa, P.; Felici, C.; Riggio, O.; Calogero, A.; Carnevale, R.; Group, S.. - In: ANTIOXIDANTS. - ISSN 2076-3921. - 10:11(2021). [10.3390/antiox10111790]

Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process

Nocella C.;Bartimoccia S.;Cammisotto V.;D'amico A.;Pastori D.;Frati G.;Sciarretta S.;Rosa P.;Riggio O.;Calogero A.;Carnevale R.
;
2021

Abstract

Atherothrombosis is a frequent complication of the clinical history of patients with antiphospholipid syndrome (APS). Both atherothrombosis and APS are characterized by increased oxidative stress. Oxidative modifications are implicated in the formation of antiphospholipid antibodies, which in turn may favour the oxidative imbalance by increasing the production of reactive oxidant species (ROS) or by a direct interaction with pro-oxidant/antioxidant enzymes. As a result of these processes, APS patients suffer from an oxidative imbalance that may contribute to the progression of the atherosclerotic process and to the onset of ischemic thrombotic complications. The aim of this review is to describe mechanisms implicated in the formation of ROS in APS patients and their involvement in the atherothrombotic process. We also provide an overview of potential therapeutic approaches to blunt oxidative stress and to prevent atherothrombotic complications in these patients.
2021
antioxidant treatment; antiphospholipid syndrome; oxidative stress; thrombosis
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Oxidative stress in the pathogenesis of antiphospholipid syndrome. Implications for the atherothrombotic process / Nocella, C.; Bartimoccia, S.; Cammisotto, V.; D'Amico, A.; Pastori, D.; Frati, G.; Sciarretta, S.; Rosa, P.; Felici, C.; Riggio, O.; Calogero, A.; Carnevale, R.; Group, S.. - In: ANTIOXIDANTS. - ISSN 2076-3921. - 10:11(2021). [10.3390/antiox10111790]
File allegati a questo prodotto
File Dimensione Formato  
Noella_Oxidative_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.09 MB
Formato Adobe PDF
1.09 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1639298
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact